WHO defends Covid-19 drug study after remdesivir maker Gilead questions methodology

HONG KONG, Oct 19 (SCMP): The World Health Organisation (WHO) has defended a study that sparked a debate about whether the antiviral drug remdesivir is any use in treating Covid-19.

The report was based on a large-scale clinical trial of four drugs that concluded none of them helped reduce mortality or the amount of time patients spent in hospital.